MapLight Therapeutics (MPLT) 2026 meeting elects directors and ratifies auditor
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. reported the results of its 2026 annual meeting of stockholders. Of the 42,610,079 shares outstanding as of the record date, 36,883,750 shares, or approximately 86.56%, were present or represented by proxy, indicating strong participation.
Stockholders elected three directors to serve until the 2029 annual meeting. Martin Babler received 31,424,194 votes for and 3,575,737 withheld, Troy Cox received 34,979,012 votes for and 20,919 withheld, and George Pavlov received 34,220,342 votes for and 779,589 withheld, with 1,883,819 broker non-votes.
Stockholders also ratified the selection of RSM US LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 36,859,217 votes for, 22,332 against, and 2,201 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding: 42,610,079 shares
Shares represented at meeting: 36,883,750 shares
Votes for Babler: 31,424,194 votes
+3 more
6 metrics
Shares outstanding
42,610,079 shares
Outstanding as of the record date for the 2026 annual meeting
Shares represented at meeting
36,883,750 shares
Approximately 86.56% participation at 2026 annual meeting
Votes for Babler
31,424,194 votes
Director election of Martin Babler
Votes for Cox
34,979,012 votes
Director election of Troy Cox
Votes for Pavlov
34,220,342 votes
Director election of George Pavlov
Votes for auditor ratification
36,859,217 votes
Ratification of RSM US LLP for fiscal year ending December 31, 2026
Key Terms
broker non-votes, independent registered public accounting firm, emerging growth company, annual meeting of stockholders
4 terms
broker non-votes financial
"Broker Non-Votes: 1,883,819"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"Ratification of the selection of RSM US LLP as independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
annual meeting of stockholders financial
"held its 2026 annual meeting of stockholders (the “Annual Meeting”)"
FAQ
What did MapLight Therapeutics (MPLT) report from its 2026 annual meeting?
MapLight Therapeutics reported voting results from its 2026 annual meeting of stockholders. Shareholders elected three directors for terms expiring at the 2029 annual meeting and ratified RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Who was elected to the MapLight Therapeutics (MPLT) board at the 2026 meeting?
Shareholders elected Martin Babler, Troy Cox, and George Pavlov to the MapLight Therapeutics board. Each will serve as a director until the 2029 annual meeting of stockholders and until a successor is elected and qualified, based on majority support in the shareholder vote.
What were the vote totals for MapLight Therapeutics (MPLT) director elections?
For director elections, Martin Babler received 31,424,194 votes for and 3,575,737 withheld. Troy Cox received 34,979,012 for and 20,919 withheld, while George Pavlov received 34,220,342 for and 779,589 withheld. There were 1,883,819 broker non-votes for this proposal.